Abstract Drug-induced calculi represent 1–2% of all renal calculi. The drugs reported to
produce calculi may be divided into two groups. The first one includes poorly soluble drugs …

Urolithiasis and nephrocalcinosis are more frequent in children then currently anticipated,
but still remain under-or misdiagnosed in a significant proportion of patients, since …

The surging growth of clinical and pharmaceutical medication as a consequence of
population growth has become a threat to the environment. The inherent antagonistic effects …

Many different drugs and agents may cause nephrotoxic acute kidney injury (AKI) in
children. Predisposing factors such as age, pharmacogenetics, underlying disease, the …

ABSTRACT A rapid and specific high-performance liquid chromatography method with UV
detection (HPLC-UV) for the simultaneous determination of 12 beta-lactam antibiotics …

In the present review we have attempted to assess the involvement of the organic anion
transporters OAT1, OAT2, OAT3, and OAT4, belonging to the SLC22 family of polyspecific …

Drug-induced nephrolithiasis contributes to 1–2% of the incidence of renal calculi. We
examined whether ceftriaxone at therapeutic doses could be crystallized in the urine and …

Drug-induced nephrolithiasis is a rare condition in children. The involved drugs may be
divided into two different categories according to the mechanism involved in calculi …

Ceftriaxone is an antibiotic agent frequently used in paediatric hospital practice for the
treatment of severe bacterial infections. The use of this agent can result in cholelithiasis …

Background More than 30 years since it was developed for clinical use, the third-generation
cephalosporin ceftriaxone remains the most commonly used agent for outpatient parental …